Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content


Hot Topics of the Day|PHGKB
Search PHGKB:

01/22/2020

Hot Topics of the Day are picked by experts to capture the latest information and publications on public health genomics and precision health for various diseases and health topics. Sources include published scientific literature, reviews, blogs and popular press articles.

Sign up MyPHGKB to receive the daily hot topic email alert.

Search Archive:
Archived Hot Topics of the Day By Date

FH as a Prototype for Precision Public Health
The FH Foundation, 2019 FH Global summit, day 2 highlights, January 2020

Dr. Muin Khoury kicked off Day 2 by discussing how FH sets the stage for precision public health for other inherited conditions. Khoury underscored the importance of data for more precisely developing and delivering public health programs to sub-populations:“Families live across states and healthcare systems. We can’t do this without precision.”

A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia.
Di Taranto Maria Donata et al. Journal of clinical medicine 2020 Jan 9(1)

An exploration of smokeless tobacco product nucleic acids: a combined metagenome and metatranscriptome analysis.
Tyx R E et al. Applied microbiology and biotechnology 2020 Jan 104(2) 751-763

Celebrating the career and contributions of Dr Henry T. Lynch (1928-2019).
Butel-Simoes Grace I et al. Internal medicine journal 2020 Jan 50(1) 108-109

This article celebrates the career of Dr Henry Lynch and his contributions to cancer genetics through his extensive research, clinical practice and his passion for personalising care by using a patient's genetic profile to determine management and treatment. Dr Lynch's contributions were momentous and continue to have relevance to medical practice.

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat Nasim et al. Breast cancer research : BCR 2020 Jan 22(1) 8

We found no evidence that RRSO reduces breast cancer risk for BRCA1 mutation carriers. A potentially beneficial effect for BRCA2 mutation carriers was observed, particularly after 5 years following RRSO. These results may inform counselling and management of carriers with respect to RRSO.


Disclaimer: Articles listed in Hot Topics of the Day are selected by Public Health Genomics Branch to provide current awareness of the scientific literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
TOP